Cancer Diagnostics – Products

therascreen EGFR RGQ Plasma PCR kit helps physicians to identify patients who could benefit from treatment with IRESSA when tumor tissue sample is not evaluable.

latest offering in the company’s Droplet Digital™ PCR line of predesigned, fully wet-lab validated assays.

Enterprise solution package for labs includes panels targeting most relevant cancer genes, bioinformatics software, report generation, staff training, technical support and gene panel updates.

Swift Biosciences, Inc. announced the launch of an early access program for Accel-NGS™ Amplicon Panels for use with Illumina Next Generation Sequencing (NGS) systems.

Senior executives on hand to discuss collaborative research with MGH aimed at developing routine blood based tests for cancer.

First major service extension to the company's BRCAvantage™ BRCA1 and BRCA2 mutation test menu offers screening for five new non-BRCA genes shown to increase risk of inherited breast cancer.

New data suggest the possibility of a simple blood test for cancers.

Highly sensitive and easy-to-use technology validated in over 100 papers in three years.

Optimized for ctDNA and cfDNA library preparation.

A companion diagnostic to advance precision medicine for melanoma.